BOULDER, Colo., June 1, 2017 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Operating Officer, Andy Robbins, will present at the Goldman Sachs 38th Annual Global Healthcare Conference. The public is welcome to participate in the conference through a webcast on the Array BioPharma website. 



    Event:     Goldman Sachs 38th Annual Global Healthcare Conference

    Presenter: Andy Robbins, Chief Operating Officer

    Date:      Tuesday, June 13, 2017

    Time:      10:00 a.m. Pacific Time

    Webcast:   https://cc.talkpoint.com/gold006/061317a_as/?entity=52_O16UKUL

About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Seven Array-owned or partnered drugs are advancing in registration studies: binimetinib (MEK162), encorafenib (LGX818), selumetinib (partnered with AstraZeneca), danoprevir (partnered with Roche), larotrectinib (partnered with Loxo Oncology), tucatinib (partnered with Cascadian Therapeutics) and ipatasertib (partnered with Roche).



    CONTACT:                        Tricia Haugeto

                                    Array BioPharma Inc.

                                    303-386-1193

                                    thaugeto@arraybiopharma.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/array-biopharma-to-present-at-the-goldman-sachs-38th-annual-global-healthcare-conference-300466999.html

SOURCE Array BioPharma Inc.